| Accession number . | Gene name . | Mass . | Coverage, maximum . | Matched peptides, maximum . | Unique peptides, maximum . | ACBD5/control ratio, average . | Number of experiments detected . |
|---|---|---|---|---|---|---|---|
| D | % | ||||||
| Q528D3 | ACBD5 | 60,092 | 16.0 | 8 | 8 | >10 | 3/3 |
| O95292 | VAPB | 27,228 | 51.4 | 16 | 14 | 4.8 | 3/3 |
| A8KA83 | VAPA | 27,318 | 47.9 | 20 | 18 | 7.7 | 2/3 |
| Accession number . | Gene name . | Mass . | Coverage, maximum . | Matched peptides, maximum . | Unique peptides, maximum . | ACBD5/control ratio, average . | Number of experiments detected . |
|---|---|---|---|---|---|---|---|
| D | % | ||||||
| Q528D3 | ACBD5 | 60,092 | 16.0 | 8 | 8 | >10 | 3/3 |
| O95292 | VAPB | 27,228 | 51.4 | 16 | 14 | 4.8 | 3/3 |
| A8KA83 | VAPA | 27,318 | 47.9 | 20 | 18 | 7.7 | 2/3 |
Results from three experiments. GFP was used as a control. Protein abundance was quantified by label-free peptide counting.